Molecule Structure

Scientific Name

Mitomycin

Description of the Drug

Mitomycin is an antimetabolite used as an adjunct to ab externo (outside approach) eye surgeries for the treatment of glaucoma and used as a chemotherapeutic agent for various malignancies.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00305

Brand Name(s)

Jelmyto, Mitomycin, Mitosol, Mitozytrex, Mutamycin, Mytozytrex

Company Owner(s)

Hong Kong King Friend Industrial Co Ltd, Urogen Pharma Ltd, Hospira Inc, Hikma Pharmaceuticals Usa Inc, Bristol Myers Co, Mobius Therapeutics Llc, Gland Pharma Ltd, Accord Healthcare Inc, Supergen Inc, Bristol Laboratories Inc Div Bristol Myers Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL3760
PharmGKB PA450524
Human Metabolome Database HMDB0014450
DrugBank DB00305
PubChem: Thomson Pharma 14924490 14899962
PubChem 5746
NMRShiftDB 60022191
LINCS LSM-6310
Nikkaji J64.512E
BindingDB 50428658
EPA CompTox Dashboard DTXSID2020898
DrugCentral 1819
Metabolights MTBLC27504
Brenda 3150 229659 151036 229660
ChemicalBook CB8456544
Guide to Pharmacology 7089
rxnorm MITOSOL MUTAMYCIN MITOMYCIN JELMYTO
KEGG Ligand C06681
ChEBI 27504
ZINC ZINC000030726187